No results for ‘’
Sunrest Lifescience Ltd
NSE: SUNREST BSE: 91669
₹35
(2.78%)
Wed, 10 Jun 2026, 04:09 am
Market Cap (in Cr)15.02
PE Ratio8.53
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSunrest Lifescience Income Statement
| Particulars | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total revenue | 240.44M | 294.72M | 333.94M |
| Gross profit | 61.12M | 57.52M | 85.38M |
| Operating expenses (excl. COGS) | -33.38M | -49.41M | -56.13M |
| Selling/general/admin expenses, total | -33.35M | -49.40M | -56.00M |
| Research & development | — | 0 | 0 |
| Selling/general/admin expenses, other | -33.35M | -49.40M | -56.00M |
| Other operating expenses, total | -23.00K | -14.00K | -134.00K |
| Operating income | 27.75M | 8.10M | 29.25M |
| Non-operating income, total | -310.00K | -2.17M | -3.02M |
| Interest expense, net of interest capitalized | -591.00K | -2.18M | -3.06M |
| Interest capitalized | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 281.00K | 10.00K | 41.00K |
| Non-operating interest income | 0 | 0 | 12.00K |
| Miscellaneous non-operating expense | 281.00K | 10.00K | 29.00K |
| Unusual income/expense | 0 | 0 | 0 |
| Pretax income | 27.44M | 5.93M | 26.23M |
| Taxes | -7.01M | -3.67M | -6.13M |
| Non-controlling/minority interest | 0 | 0 | -53.00K |
| After tax other income/expense | 0 | 0 | 0 |
| Net income before discontinued operations | 20.43M | 2.26M | 20.05M |
| Net income | 20.43M | 2.26M | 20.05M |
| Dilution adjustment | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 20.43M | 2.26M | 20.05M |
| Basic earnings per share (Basic EPS) | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - |
| EBITDA | 29.05M | 9.07M | 30.20M |
| EBIT | 27.75M | 8.10M | 29.25M |
| Total operating expenses | -212.69M | -286.62M | -304.69M |
| Prepaid expenses | 2.51M | 3.25M | 4.20M |
| Deferred income, current | 1.59M | 2.62M | 0 |
| Capital and operating lease obligations | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — |
| Deferred tax liabilities | — | — | — |
| Deferred income, non-current | — | — | — |
| Minority interest | 0 | 0 | 53.19M |
| Change in accrued expenses | — | — | — |
| Common dividends paid | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 |